Interim Research and Development Reports. The NIH CRADA Extramural Investigator/Officer(s) and CRADA Collaborator PI(s) should exchange information regularly, in writing. This exchange may be accomplished through meeting minutes, detailed correspondence, circulation of draft manuscripts, Steering Committee reports, copies of Annual Reports and any other reports updating the progress of the CRADA research. However, the Parties must exchange updated Investigator’s Brochure, formulation and preclinical data, and toxicology findings, as they become available.
Appears in 3 contracts
Samples: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement (Raptor Pharmaceutical Corp), Cooperative Research and Development Agreement
Interim Research and Development Reports. The NIH CRADA Extramural Investigator/Officer(s) Officers and CRADA Collaborator PI(s) PIs should exchange information regularlyregularly (e.g., at least [ * ], or as appropriate for the stage of the research being conducted under the CRADA), in writing. This exchange may be accomplished through meeting minutes, detailed correspondence, circulation of draft manuscripts, Steering Committee reports, copies of Annual Reports and any other reports updating the progress of the CRADA research. However, the Parties must exchange updated Investigator’s Brochure, safety, formulation and preclinical data, and toxicology findings, findings related to the Investigational Agent as they become available.
Appears in 1 contract
Samples: Cooperative Research and Development Agreement (Exelixis, Inc.)